Gastrointestinal Stromal Tumors
Showing NaN - NaN of 8
Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)
Completed
- Gastrointestinal Stromal Tumors
- DCC-2618
- Placebo Oral Tablet
-
Scottsdale, Arizona
- +34 more
Nov 17, 2022
Gastrointestinal Stromal Tumors Trial in Toronto (BBI503)
Terminated
- Gastrointestinal Stromal Tumors
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 4, 2022
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506), Placebo, Best supportive care)
Completed
- Gastrointestinal Stromal Tumors
- Regorafenib (Stivarga, BAY73-4506)
- +2 more
-
Scottsdale, Arizona
- +56 more
Jan 27, 2021
Disorder of Upper Gastrointestinal Tract, Gastrointestinal Stromal Tumors, Gastrointestinal Tumors Trial in Toronto (EUS-guided
Unknown status
- Disorder of Upper Gastrointestinal Tract
- +2 more
- EUS-guided fine needle biopsy
- Single incision needle knife biopsy
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Aug 9, 2016
Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)
Completed
- Gastrointestinal Stromal Tumors
- Nilotinib
- Best Supportive Care (BSC) +/- imatinib or sunitinib
-
Los Angeles, California
- +34 more
Jun 5, 2012
Gastrointestinal Stromal Tumors, Soft Tissue Sarcomas Trial in Canada, United States (IPI-504)
Completed
- Gastrointestinal Stromal Tumors
- Soft Tissue Sarcomas
-
Scottsdale, Arizona
- +4 more
Jan 5, 2011